To further validate whether CXCL12 mediated the effect of iCAFs on lung cancer cell migration and invasion, CXCL12 neutralizing antibody was applied to iCAF-CM and cultured lung cancer cells. This evidence concerns the gene CXCL12 and lung carcinoma.